Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Study on Potential Biomarkers Associated With Clinical Phenotype of EGFR-TKIs in No-small Cell Lung Cancer in China
ClinicalTrials.gov study NCT02381808. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC
ClinicalTrials.gov study NCT05805631. IPD Sharing: NO. Countries: 0. Publications: 0.
Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer
ClinicalTrials.gov study NCT01967095. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC
ClinicalTrials.gov study NCT04587128. IPD Sharing: NO. Countries: 1. Publications: 0.
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
ClinicalTrials.gov study NCT05163028. IPD Sharing: NO. Countries: 2. Publications: 0.
Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung Cancer
ClinicalTrials.gov study NCT04592666. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification
ClinicalTrials.gov study NCT04880811. IPD Sharing: NO. Countries: 1. Publications: 0.
PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery
ClinicalTrials.gov study NCT02804776. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT03392246. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash
ClinicalTrials.gov study NCT00656786. IPD Sharing: Not stated. Countries: 2. Publications: 0.
BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations
ClinicalTrials.gov study NCT06032936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
ClinicalTrials.gov study NCT01776684. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Primary Tumor Resection With EGFR TKI for Stage IV NSCLC
ClinicalTrials.gov study NCT05215548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acquired Resistant Mechanism of the First-generation EGFR TKIs
ClinicalTrials.gov study NCT02804217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC
ClinicalTrials.gov study NCT06816992. IPD Sharing: NO. Countries: 3. Publications: 0.
A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT03082300. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis
ClinicalTrials.gov study NCT06352502. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities
ClinicalTrials.gov study NCT04982900. IPD Sharing: NO. Countries: 1. Publications: 0.
Combining Afatinib and Concurrent Chemotherapy, Followed by Osimertinib and Concurrent Chemotherapy, in Untreated EGFR Positive NSCLC Tumors
ClinicalTrials.gov study NCT05298176. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers
ClinicalTrials.gov study NCT06164574. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.